Association between mobilization regimen and PFS after auto-SCT for multiple myeloma

Bone Marrow Transplant. 2014 Nov;49(11):1439-41. doi: 10.1038/bmt.2014.153. Epub 2014 Jul 21.

Authors

A L Garfall¹, A L Dougherty¹, D T Vogl¹, B M Weiss¹, A D Cohen¹, R Mick², U O'Doherty³, E A Stadtmauer¹

Affiliations

¹ Hematologic Malignancies Program, Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
² Center for Clinical Epidemiology & Biostatistics, Department of Biostatistics & Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
³ Division of Transfusion Medicine, Department of Pathology & Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Anti-HIV Agents / administration & dosage*
Autografts
Benzylamines
Cyclams
Disease-Free Survival
Female
Filgrastim
Granulocyte Colony-Stimulating Factor / administration & dosage*
Hematopoietic Stem Cell Mobilization
Heterocyclic Compounds / administration & dosage*
Humans
Male
Middle Aged
Multiple Myeloma / mortality*
Multiple Myeloma / therapy*
Recombinant Proteins / administration & dosage
Retrospective Studies
Stem Cell Transplantation*
Survival Rate

Substances

Anti-HIV Agents
Benzylamines
Cyclams
Heterocyclic Compounds
Recombinant Proteins
Granulocyte Colony-Stimulating Factor
Filgrastim
plerixafor

Grants and funding